Public drug program spending in Canada by top drug classes 2022

Published by
Matej Mikulic,
Dec 6, 2023
This statistic shows the top 10 drug classes in Canada based on share of total public drug program spending in 2022. In that year, 1.9 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.

Leading 10 drug classes by share of total public drug program spending in Canada in 2022

CharacteristicShare of total public drug program spending
Tumour necrosis factor alpha inhibitors (anti-TNF drugs) 6.2%
Antineovascularization agents 5.3%
Selective immunosuppressants 3.6%
Direct factor Xa inhibitors 3%
Glucagon-like peptide-1 (GLP-1) analogues 2.6%
Sodium–glucose co-transporter 2 (SGLT2) inhibitors 2.4%
Interleukin inhibitors 2.2%
Other antipsychotics 2.2%
HMG-CoA reductase inhibitors (statins) 1.9%
Other respiratory system products 1.7%
Showing entries 1 to 10 (10 entries in total)
Created with Highcharts 7.2.2Share of total public drug program spending6.2%6.2%5.3%5.3%3.6%3.6%3%3%2.6%2.6%2.4%2.4%2.2%2.2%2.2%2.2%1.9%1.9%1.7%1.7%Tumour necrosis factor alpha inhibitors (anti-TNF drugs)Antineovascularization agentsSelective immunosuppressantsDirect factor Xa inhibitorsGlucagon-like peptide-1 (GLP-1) analoguesSodium–glucose co-transporter 2 (SGLT2) inhibitorsInterleukin inhibitorsOther antipsychoticsHMG-CoA reductase inhibitors (statins)Other respiratory system products
0%0.5%1%1.5%2%2.5%3%3.5%4%4.5%5%5.5%6%6.5%7%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

November 2023

Region

Canada

Survey time period

2022

Supplementary notes

Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on " Health care system in Canada "

Other statistics that may interest you Health care system in Canada

Overview

4

Health expenditure

7

Medical personnel

7

Prescription drug coverage

5

Access to care

5

Outlook

6

Public opinion

7

Discover Statista

Need help with using Statista for your research? Tutorials and first steps
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.